Search results
Results From The WOW.Com Content Network
SELLAS Life Sciences Group Inc (NASDAQ: SLS) announced topline data from its Phase 1/2 trial of galinpepimut-S (GPS) in WT1(+) relapsed or refractory platinum-resistant advanced metastatic ovarian ...
Number of employees. 60 (March 2014) Website. www.sellaslifesciences.com. Galena Biopharma, Inc. (originally RXi Pharmaceuticals) was a publicly traded pharmaceutical company based in San Ramon, California. The company was founded in Worcester, Massachusetts. In 2011, it moved to Oregon, [1][2] and in 2015 moved to San Ramon, California. [3]
GenFleet Therapeutics has granted GFH009 rights to SELLAS Life Sciences Group Inc (NASDAQ: SLS) across all therapeutic and diagnostic uses worldwide outside of Greater China (mainland China, Hong ...
For premium support please call: 800-290-4726 more ways to reach us
The biotechnology sector is growing in the New York City area, based upon the region's strength in academic scientific research and public and commercial financial support. By mid-2014, Accelerator, a biotech investment firm, had raised more than US$30 million from investors, including Eli Lilly and Company, Pfizer, and Johnson & Johnson, for ...
ScienceAlert is an independently run online publication and news source that publishes articles featuring scientific research, discoveries, and outcomes. [2] The site was founded in 2004 by Julian Cribb, a science writer, to aggregate research findings from Australian universities, [7] and it expanded in 2006 when ex-Microsoft programmer Chris Cassella took on the project of developing the ...
For example, SELLAS Life Sciences... Skip to main content. Sign in. Mail. 24/7 Help. For premium support please call: 800-290-4726 more ways to reach us. Mail. Sign in ... News; Online Classes;
Website. www.zyduslife.com. Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, [3] is an Indian multinational pharmaceutical company headquartered in Ahmedabad, which is primarily engaged in the manufacturing of generic drugs. [4][5][6] The company ranked 100th in the Fortune India 500 list in 2020. [7]